| Original language | English |
|---|---|
| Journal | Frontiers in Immunology |
| Volume | 8 |
| Issue number | MAR |
| DOIs | |
| Publication status | Published - 2017 |
Cite this
Varricchi, G., Senna, G., Loffredo, S., Bagnasco, D., Ferrando, M., & Canonica, G. W. (2017). Reslizumab and eosinophilic asthma: One step closer to precision medicine? Frontiers in Immunology, 8(MAR). https://doi.org/10.3389/fimmu.2017.00242
Reslizumab and eosinophilic asthma: One step closer to precision medicine? / Varricchi, G.; Senna, G.; Loffredo, S.; Bagnasco, D.; Ferrando, M.; Canonica, G.W.
In: Frontiers in Immunology, Vol. 8, No. MAR, 2017.Research output: Contribution to journal › Article
Varricchi, G, Senna, G, Loffredo, S, Bagnasco, D, Ferrando, M & Canonica, GW 2017, 'Reslizumab and eosinophilic asthma: One step closer to precision medicine?', Frontiers in Immunology, vol. 8, no. MAR. https://doi.org/10.3389/fimmu.2017.00242
Varricchi G, Senna G, Loffredo S, Bagnasco D, Ferrando M, Canonica GW. Reslizumab and eosinophilic asthma: One step closer to precision medicine? Frontiers in Immunology. 2017;8(MAR). https://doi.org/10.3389/fimmu.2017.00242
@article{f581a43fc59e4144a9ac08da3d104617,
title = "Reslizumab and eosinophilic asthma: One step closer to precision medicine?",
author = "G. Varricchi and G. Senna and S. Loffredo and D. Bagnasco and M. Ferrando and G.W. Canonica",
year = "2017",
doi = "10.3389/fimmu.2017.00242",
language = "English",
volume = "8",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "MAR",
}
TY - JOUR
T1 - Reslizumab and eosinophilic asthma: One step closer to precision medicine?
AU - Varricchi, G.
AU - Senna, G.
AU - Loffredo, S.
AU - Bagnasco, D.
AU - Ferrando, M.
AU - Canonica, G.W.
PY - 2017
Y1 - 2017
U2 - 10.3389/fimmu.2017.00242
DO - 10.3389/fimmu.2017.00242
M3 - Article
C2 - 28344579
VL - 8
JO - Frontiers in Immunology
JF - Frontiers in Immunology
SN - 1664-3224
IS - MAR
ER -